This is a preview of subscription content, log in via an institution to check access.
Reference
Ronconi G, et al. Real-world Prescription Pattern, Discontinuation and Costs of Ibrutinib-Naive Patients with Chronic Lymphocytic Leukemia: An Italian Healthcare Administrative Database Analysis. Clinical Drug Investigation : 25 May 2021. Available from: URL: http://doi.org/10.1007/s40261-021-01044-3
Rights and permissions
About this article
Cite this article
Ibrutinib for chronic lymphocytic leukaemia in Italy: high discontinuation rates for costly therapy. PharmacoEcon Outcomes News 880, 18 (2021). https://doi.org/10.1007/s40274-021-7776-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-021-7776-y